A detailed history of Sabadell Asset Management, S.A S.G.I.I.C transactions in Moderna, Inc. stock. As of the latest transaction made, Sabadell Asset Management, S.A S.G.I.I.C holds 1,416 shares of MRNA stock, worth $55,776. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,416
Previous 1,416 -0.0%
Holding current value
$55,776
Previous $219 Million 21.27%
% of portfolio
0.04%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jan 23, 2024

BUY
$129.91 - $234.98 $183,952 - $332,731
1,416 New
1,416 $333 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sabadell Asset Management, S.A S.G.I.I.C Portfolio

Follow Sabadell Asset Management, S.A S.G.I.I.C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabadell Asset Management, S.A S.G.I.I.C, based on Form 13F filings with the SEC.

News

Stay updated on Sabadell Asset Management, S.A S.G.I.I.C with notifications on news.